The adoption of alcohol pharmacotherapies in the Clinical Trials Network: The influence of research network participation

Journal of Substance Abuse Treatment

Volumn 38, Issue 3, 2010, Pages 275-283

  Abraham, Amanda J ^a   Knudsen, Hannah K ^b   Rothrauff, Tanja C ^a   Roman, Paul M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Acamprosate; Adoption of innovations; Clinical Trials Network; Research networks; Tablet naltrexone

Indexed keywords

ACAMPROSATE; NALTREXONE;

ALCOHOLISM; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; FOLLOW UP; FUNDING; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; PATIENT PARTICIPATION; PRIORITY JOURNAL; TABLET; TREATMENT DURATION;

ALCOHOL DETERRENTS; ALCOHOLISM; CLINICAL TRIALS AS TOPIC; DIFFUSION OF INNOVATION; FOLLOW-UP STUDIES; HEALTH SERVICES RESEARCH; HUMANS; NALTREXONE; NITROSAMINES; ORGANIZATIONAL CULTURE; ORGANIZATIONAL INNOVATION; SUBSTANCE ABUSE TREATMENT CENTERS; TAURINE; UNITED STATES;

EID: 77649189454     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2010.01.003     Document Type: Article

References (51)

1. Abraham A.J., Ducharme L.J., and Roman P.M. Counselor attitudes toward pharmacotherapy for alcohol dependence. Journal of Studies on Alcohol and Drugs 70 (2009) 628-635
2. Ahuja G. Collaboration networks, structural holes, and innovation: A longitudinal study. Administrative Science Quarterly 45 (2000) 425-455
3. Becker M.H. Sociometric location and innovativeness: Reformulation and extension of the diffusion model. American Sociological Review 35 (1970) 262-282
4. Carroll K.M., and Rounsaville B.J. Bridging the gap: A hybrid model to link efficacy and effectiveness research in substance abuse treatment. Psychiatric Services 54 (2003) 333-339
5. Cohen W.M., and Levinthal D.A. Absorptive capacity: A new perspective on learning and innovation. Administrative Science Quarterly 35 (1990) 128-152
6. Coleman J.S., Katz S.E., and Menzel H. Medical innovation (1966), Bobbs-Merrill, New York
7. Ducharme L.J., Knudsen H.K., and Roman P.M. Trends in the adoption of medications for alcohol dependence. Journal of Clinical Psychopharmacology 26 (2006) S13-S19 (PMID: 17114950)
8. Ducharme L.J., Knudsen H.K., and Roman P.M. Evidence-based treatment for opiate-dependent patients: Availability, variation, and organizational correlates. American Journal of Drug and Alcohol Abuse 32 (2006) 569-575 (PMID: 17127545)
9. Ducharme L.J., Knudsen H.K., Roman P.M., and Johnson J.A. Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network. Journal of Substance Abuse Treatment 32 (2007) 321-329 (PMID: 17481455)
10. Erickson C.L., and Jacoby S.M. The effect of employer networks on workplace innovation and training. Industrial and Labor Relations Review 56 (2003) 203-223
11. Fennell M.L., and Warnecke R.B. The diffusion of medical innovations (1988), Plenum, New York
12. Fuller B.E., Rieckmann T., McCarty D., Smith K.W., and Levine H. Adoption of naltrexone to treat alcohol dependence. Journal of Substance Abuse Treatment 28 (2005) 273-280
13. Gibbons D.E. Interorganizational network structure and diffusion of information through a health care system. American Journal of Public Health 97 (2007) 1684-1692
14. Goes J.B., and Park S.H. Interorganizational links and innovation: The case of hospital services. Academy of Management 40 (1997) 673-696
15. Haug N.A., Shopshire M., Tajima B., Gruber V., and Guydish J. Adoption of evidence-based practices among substance abuse treatment providers. Journal of Drug Education 38 (2008) 181-192
16. Heinrich C.J., and Hill C.J. Role of state policies in the adoption of naltrexone for substance abuse treatment. Health Services Research 43 (2008) 951-970
17. Henggler S.W., Chapman J.E., Rowland M.D., Halliday-Boykins C.A., Randall J., Shackelford J., et al. Statewide adoption and initial implementation of contingency management for substance-abusing adolescents. Journal of Consulting and Clinical Psychology 76 (2008) 556-567
18. Institute of Medicine. Improving the quality of health care for mental and substance-use disorders: Quality chasm series (2006), National Academy Press, Washington, DC
19. Kirby K.C., Benishek L.A., Dugosh K.L., and Kerwin M.E. Substance abuse treatment providers' beliefs and objections regarding contingency management: Implications for dissemination. Drug and Alcohol Dependence 85 (2006) 19-27
20. Knudsen H.K., Abraham A.J., Johnson J.A., and Roman P.M. Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment 37 (2009) 307-312
21. Knudsen H.K., Ducharme L.J., and Roman P.M. Early buprenorphine adoption in substance abuse treatment centers: Data from the private and public sectors. Journal of Substance Abuse Treatment 30 (2006) 363-373 (PMID: 16716852)
22. Knudsen H.K., Ducharme L.J., and Roman P.M. The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clusters. Drug and Alcohol Dependence 87 (2007) 164-174 (PMID: 16971059)
23. Knudsen H.K., Ducharme L.J., and Roman P.M. Racial and ethnic disparities in SSRI availability in substance abuse treatment. Psychiatric Services 58 (2007) 55-62
24. Knudsen H.K., Ducharme L.J., Roman P.M., and Link T. Buprenorphine diffusion: The attitudes of substance abuse treatment counselors. Journal of Substance Abuse Treatment 29 (2005) 95-106
25. Knudsen H.K., and Roman P.M. Modeling the use of innovations in private treatment organizations: The role of absorptive capacity. Journal of Substance Abuse Treatment 26 (2004) 353-361 (PMID: 14698799)
26. Knudsen, H. K., Roman, P. M., & Oser, C. B. (in press). Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations. Journal of Addiction Medicine.
27. Laliberte L., Fennell M.L., and Papandonatos G. The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer. Medical Care 43 (2005) 471-479
28. Lamb S., Greenlick M.R., and McCarty D.E. Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment (1998), National Academy Press, Washington, D.C.
29. Long J.S., and Freese J. Regression models for categorical dependent variables using Stata. 2nd ed. (2006), Stata Corporation, College Station
30. Mansfield E. Technological change (1971), W.W. Norton, New York
31. McCarty D., Rieckmann T., Green C., Gallon S., and Knudsen J. Training rural practitioners to use buprenorphine: Using The Change Book to facilitate technology transfer. Journal of Substance Abuse Treatment 26 (2004) 203-208
32. McGovern M., Fox T., Xie H., and Drake R.E. A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an addiction treatment system. Journal of Substance Abuse Treatment 26 (2004) 305-312
33. McLellan A.T., and Meyers K. Contemporary addiction treatment: A review of systems problems for adults and adolescents. Biological Psychiatry 56 (2004) 764-770
34. Mee-Lee D.L., Gartner L., Miller M.M., Shulman G.D., and Wilford B.B. Patient placement criteria for the treatment of substance-related disorders. 2nd ed. (1996), ASAM, Chevy Chase, MD
35. Miller W.R., Sorensen J.L., Selzer J.A., and Brigham G.S. Disseminating evidence-based practices in substance abuse treatment: A review with suggestions. Journal of Substance Abuse Treatment 31 (2006) 25-39
36. Oser C.B., and Roman P.M. Organizational-level correlates of adoption over time: Naltrexone in private substance use-disorders treatment centers. Journal of Studies on Alcohol and Drugs 68 (2007) 852-861
37. Oser C.B., and Roman P.M. A categorical typology of naltrexone-adopting private substance abuse treatment centers. Journal of Substance Abuse Treatment 34 (2008) 433-442
38. Petry N.M., and Simcic Jr. F. Recent advances in the dissemination of contingency management techniques: Clinical and research perspectives. Journal of Substance Abuse Treatment 23 (2002) 81-86
39. Pittaway L., Robertson M., Munir K., Denyer D., and Neely A. Networking and innovation: A systematic review of the evidence. International Journal of Management Reviews 5/6 (2004) 137-168
40. Powell W.W., Koput K.W., and Smith-Doerr L. Interoganizational collaboration and the locus of innovation: Networks of learning in technology. Administrative Science Quarterly 41 (1996) 116-145
41. Rogers E.M. Diffusion of innovations. 5th ed. (2003), Free Press, New York
42. Roman P.M., and Johnson J.A. Adoption and implementation of new technologies in substance abuse treatment. Journal of Substance Abuse Treatment 22 (2002) 211-218
43. Sholomskas D.E., Syracuse-Siewert G., Rounsaville B., Ball S.A., Nuro K.F., and Carroll K.M. We don't train in vain: A dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. Journal of Consulting and Clinical Psychology 73 (2005) 106-115
44. StataCorp. Stata Statistical Software: Version 10 (2007), StataCorp LP, College Station (Tex)
45. Thomas C.P., Wallack S.S., Lee S., McCarty D., and Swift R. Research to practice: Adoption of naltrexone in alcoholism treatment. Journal of Substance Abuse Treatment 24 (2003) 1-11
46. Thomas S., and Miller P.M. Knowledge of attitudes about pharmacotherapy for alcoholism: A survey of counselors and administrators in community-based addiction treatment centers. Alcohol 42 (2007) 113-118
47. Thomas S., Miller P.M., Randall P.K., and Book S.W. Improving acceptance of naltrexone in community addiction treatment centers: A pilot study. Journal of Substance Abuse Treatment 35 (2008) 260-268
48. Varra A.A., Hayes S.C., Roget N., and Fisher G. A randomized controlled trial examining the effect of acceptance and commitment training on clinician willingness to use evidence-based pharmacotherapy. Journal of Consulting and Clinical Psychology 76 (2008) 449-458
49. 2 for binary probit models. Quality & Quantity 28 (1994) 151-164
50. Westphal J.D., Gulati R., and Shortell S.M. Customization or conformity? An institutional and network perspective on the content and consequences of TQM adoption. Administrative Science Quarterly 42 (1997) 366-394
51. Zahra S.A., and George G. Absorptive capacity: A review, reconceptualization, and extension. Academy of Management Review 27 (2002) 185-203